Professor Vijay Kumar

MSc (Med), PhD
Clinical Professor
Paediatrics & Child Health, Children's Hospital, Westmead

Telephone 02 98456533
Fax 02 98915385

Map

International links

Austria

(International Atomic Energy Agency (IAEA), Vienna.) Worked at IAEA as a Consultant Radiopharmaceutical Science Expert under Special Services Agreement, at Department of Nuclear Science Applications, in 2010. Initiated the Co-ordinated Research Project(CRP) on "Development of Ga-68 based PET-Radiopharmaceuticals for Management of Cancer and other Chronic Diseases".

Germany

(Institut fuer Kernchemie Johannes Gutenberg-Universitaet Mainz) Develop scientific projects on the preparation and evaluation of 68Ga-labelled Radiopharmaceuticals for PET-imaging.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Kumar, V., Boddeti, D. (2013). 68 Ga-Radiopharmaceuticals for PET lmaging of Infection and Inflammation. In Richard P. Baum and Frank Rosch (Eds.), Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalised Diagnosis and Treatment, (pp. 189-219). New York: Springer.
  • Kumar, V., Baker, R., Barnes, R. (2004). Fundamentals Of Radiochemistry. Radiopharmacy. In Peter Ell, Sam Gambhir (Eds.), Nuclear Medicine in Clinical Diagnosis and Treatment, (pp. 1721-1736). Edinburgh, UK: Churchill Livingstone.

Journals

  • Kumar, V., Boddeti, D., Evans, S., Angelides, S. (2012). (68)Ga-Citrate-PET for Diagnostic Imaging of Infection in Rats and for Intra-Abdominal Infection in a Patient. Current Radiopharmaceuticals, 5(1), 71-75. [More Information]
  • Ali, M., Vanniasinghe, A., Kumar, V., Barnett, R., Alberto, R., Manolios, N. (2011). 99mTc-technetium labeling of antiarthritic peptides to evaluate homing and biodistribution at inflamed joints. Nuclear Medicine and Biology, 38(5), 751-756. [More Information]
  • Kumar, V., Boddeti, D., Evans, S., Roesch, F., Howman-Giles, R. (2011). Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nuclear Medicine and Biology, 38(3), 393-398. [More Information]
  • Wong, E., Kumar, V., Howman-Giles, R., Vanderheyden, J. (2008). Imaging of Therapy-Induced Apoptosis Using 99mTc-HYNIC-Annexin V in Thymoma Tumor-Bearing Mice. Cancer Biotherapy and Radiopharmaceuticals, 23(6), 1-11. [More Information]
  • Kumar, V., Kumar, D., Howman-Giles, R., Little, D. (2007). Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging? Nuclear Medicine Communications, 28(2), 101-107. [More Information]
  • Kumar, V., Kumar, D., Howman-Giles, R., Little, D. (2007). Is Tc-99m-labelled pamidronate a better agent than Tc-99m-medronate for bone imaging? Nuclear Medicine Communications, 28(2), 101-107.
  • Kumar, V., Ali, M., Angelides, S., Manolios, N. (2007). Synthesis and characterization of 99mTc-Glucosamine & 99mTc-His-CP and evaluation of their utility in imaging inflammatory arthritis. Australian and New Zealand Nuclear Medicine, 38(3), 10-13.
  • Kumar, D., Kumar, V., Little, D., Howman-Giles, R., Wong, E., Ali, S. (2006). Evaluation of biodistribution by local versus systemic administration of (99m)Tc-labeled pamidronate. Journal of orthopaedic science, 11(5), 512-520. [More Information]
  • Kumar, V. (2006). New radiopharmaceuticals for diagnosis and treatment. World Journal of Nuclear Medicine, 5, 237-240.
  • Kumar, V. (2005). Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 49(4), 325-338. [More Information]

2013

  • Kumar, V., Boddeti, D. (2013). 68 Ga-Radiopharmaceuticals for PET lmaging of Infection and Inflammation. In Richard P. Baum and Frank Rosch (Eds.), Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalised Diagnosis and Treatment, (pp. 189-219). New York: Springer.

2012

  • Kumar, V., Boddeti, D., Evans, S., Angelides, S. (2012). (68)Ga-Citrate-PET for Diagnostic Imaging of Infection in Rats and for Intra-Abdominal Infection in a Patient. Current Radiopharmaceuticals, 5(1), 71-75. [More Information]

2011

  • Ali, M., Vanniasinghe, A., Kumar, V., Barnett, R., Alberto, R., Manolios, N. (2011). 99mTc-technetium labeling of antiarthritic peptides to evaluate homing and biodistribution at inflamed joints. Nuclear Medicine and Biology, 38(5), 751-756. [More Information]
  • Kumar, V., Boddeti, D., Evans, S., Roesch, F., Howman-Giles, R. (2011). Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nuclear Medicine and Biology, 38(3), 393-398. [More Information]

2008

  • Wong, E., Kumar, V., Howman-Giles, R., Vanderheyden, J. (2008). Imaging of Therapy-Induced Apoptosis Using 99mTc-HYNIC-Annexin V in Thymoma Tumor-Bearing Mice. Cancer Biotherapy and Radiopharmaceuticals, 23(6), 1-11. [More Information]

2007

  • Kumar, V., Kumar, D., Howman-Giles, R., Little, D. (2007). Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging? Nuclear Medicine Communications, 28(2), 101-107. [More Information]
  • Kumar, V., Kumar, D., Howman-Giles, R., Little, D. (2007). Is Tc-99m-labelled pamidronate a better agent than Tc-99m-medronate for bone imaging? Nuclear Medicine Communications, 28(2), 101-107.
  • Kumar, V., Ali, M., Angelides, S., Manolios, N. (2007). Synthesis and characterization of 99mTc-Glucosamine & 99mTc-His-CP and evaluation of their utility in imaging inflammatory arthritis. Australian and New Zealand Nuclear Medicine, 38(3), 10-13.

2006

  • Kumar, D., Kumar, V., Little, D., Howman-Giles, R., Wong, E., Ali, S. (2006). Evaluation of biodistribution by local versus systemic administration of (99m)Tc-labeled pamidronate. Journal of orthopaedic science, 11(5), 512-520. [More Information]
  • Kumar, V. (2006). New radiopharmaceuticals for diagnosis and treatment. World Journal of Nuclear Medicine, 5, 237-240.

2005

  • Kumar, V. (2005). Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 49(4), 325-338. [More Information]

2004

  • Kumar, V., Baker, R., Barnes, R. (2004). Fundamentals Of Radiochemistry. Radiopharmacy. In Peter Ell, Sam Gambhir (Eds.), Nuclear Medicine in Clinical Diagnosis and Treatment, (pp. 1721-1736). Edinburgh, UK: Churchill Livingstone.

To update your profile click here. For support on your academic profile contact .